These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 16030162)

  • 21. Approach to the male patient with congenital hypogonadotropic hypogonadism.
    Young J
    J Clin Endocrinol Metab; 2012 Mar; 97(3):707-18. PubMed ID: 22392951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antipituitary antibodies against gonadotropin-secreting cells in adult male patients with apparently idiopathic hypogonadotropic hypogonadism.
    De Bellis A; Sinisi AA; Conte M; Coronella C; Bellastella G; Esposito D; Pasquali D; Ruocco G; Bizzarro A; Bellastella A
    J Clin Endocrinol Metab; 2007 Feb; 92(2):604-7. PubMed ID: 17090639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Behavioral features of CHARGE syndrome (Hall-Hittner syndrome) comparison with Down syndrome, Prader-Willi syndrome, and Williams syndrome.
    Graham JM; Rosner B; Dykens E; Visootsak J
    Am J Med Genet A; 2005 Mar; 133A(3):240-7. PubMed ID: 15637708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CHARGE syndrome: developmental and behavioral data.
    Souriau J; Gimenes M; Blouin C; Benbrik I; Benbrik E; Churakowskyi A; Churakowskyi B
    Am J Med Genet A; 2005 Mar; 133A(3):278-81. PubMed ID: 15688422
    [No Abstract]   [Full Text] [Related]  

  • 25. Primary testicular dysfunction is a major contributor to abnormal pubertal development in males with Prader-Willi syndrome.
    Hirsch HJ; Eldar-Geva T; Benarroch F; Rubinstein O; Gross-Tsur V
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2262-8. PubMed ID: 19401370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative magnetic resonance imaging evaluation of the olfactory system in Kallmann syndrome: correlation with a clinical smell test.
    Koenigkam-Santos M; Santos AC; Versiani BR; Diniz PR; Junior JE; de Castro M
    Neuroendocrinology; 2011; 94(3):209-17. PubMed ID: 21606642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.
    Zenaty D; Garel C; Limoni C; Czernichow P; Léger J
    Clin Endocrinol (Oxf); 2003 May; 58(5):647-52. PubMed ID: 12699449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reconsidering olfactory bulb magnetic resonance patterns in Kallmann syndrome.
    Hacquart T; Ltaief-Boudrigua A; Jeannerod C; Hannoun S; Raverot G; Pugeat M; Brac de la Perriere A; Lapras V; Nugues F; Dode C; Cotton F
    Ann Endocrinol (Paris); 2017 Oct; 78(5):455-461. PubMed ID: 28807454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CHARGE syndrome "behaviors": challenges or adaptations?
    Brown D
    Am J Med Genet A; 2005 Mar; 133A(3):268-72. PubMed ID: 15666302
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of magnetic resonance imaging in the diagnosis and prognosis of growth hormone deficiency.
    Bozzola M; Adamsbaum C; Biscaldi I; Zecca M; Cisternino M; Genovese E; Richard I; Kalifa G; Chaussain JL
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):21-6. PubMed ID: 8796134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early prognostic factors for intellectual outcome in CHARGE syndrome.
    Raqbi F; Le Bihan C; Morisseau-Durand MP; Dureau P; Lyonnet S; Abadie V
    Dev Med Child Neurol; 2003 Jul; 45(7):483-8. PubMed ID: 12828403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel loss-of-function mutation in GPR54/KISS1R leads to hypogonadotropic hypogonadism in a highly consanguineous family.
    Nimri R; Lebenthal Y; Lazar L; Chevrier L; Phillip M; Bar M; Hernandez-Mora E; de Roux N; Gat-Yablonski G
    J Clin Endocrinol Metab; 2011 Mar; 96(3):E536-45. PubMed ID: 21193544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Congenital hypogonadotropic hypogonadism and Kallmann syndrome in males].
    Ghervan C; Young J
    Presse Med; 2014 Feb; 43(2):152-61. PubMed ID: 24456696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cochlear implantation in Children with CHARGE syndrome: therapeutic decisions and outcomes.
    Lanson BG; Green JE; Roland JT; Lalwani AK; Waltzman SB
    Laryngoscope; 2007 Jul; 117(7):1260-6. PubMed ID: 17507827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An epidemiological analysis of CHARGE syndrome: preliminary results from a Canadian study.
    Issekutz KA; Graham JM; Prasad C; Smith IM; Blake KD
    Am J Med Genet A; 2005 Mar; 133A(3):309-17. PubMed ID: 15637722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T-cell immunodeficiency in CHARGE syndrome.
    Chopra C; Baretto R; Duddridge M; Browning MJ
    Acta Paediatr; 2009 Feb; 98(2):408-10. PubMed ID: 18976358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A 5-year prospective study of growth hormone (GH)-deficient children treated with GH before the age of 3 years. French Serono Study Group.
    Rappaport R; Mugnier E; Limoni C; Crosnier H; Czernichow P; Leger J; Limal JM; Rochiccioli P; Soskin S
    J Clin Endocrinol Metab; 1997 Feb; 82(2):452-6. PubMed ID: 9024235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can specific deficits in executive functioning explain the behavioral characteristics of CHARGE syndrome: a case study.
    Nicholas J
    Am J Med Genet A; 2005 Mar; 133A(3):300-5. PubMed ID: 15637727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Updated diagnostic criteria for CHARGE syndrome: a proposal.
    Verloes A
    Am J Med Genet A; 2005 Mar; 133A(3):306-8. PubMed ID: 15666308
    [No Abstract]   [Full Text] [Related]  

  • 40. CHARGE syndrome: 2005.
    Carey JC
    Am J Med Genet A; 2005 Mar; 133A(3):227. PubMed ID: 15633196
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.